Charles River Laboratories International, Inc.CRLNYSE
Loading
Operating Income ScalingExpanding
Percentile Rank79
3Y CAGR-7.9%
5Y CAGR+3.3%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
-7.9%/yr
vs +18.4%/yr prior
5Y CAGR
+3.3%/yr
Recent deceleration
Acceleration
-26.3pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $507.84M | +123.4% |
| 2024 | $227.35M | -63.2% |
| 2023 | $617.26M | -5.2% |
| 2022 | $650.98M | +10.4% |
| 2021 | $589.86M | +36.3% |
| 2020 | $432.73M | +23.2% |
| 2019 | $351.15M | +6.0% |
| 2018 | $331.38M | +15.0% |
| 2017 | $288.28M | +21.4% |
| 2016 | $237.55M | - |